#POLB Poolbeg Pharma PLC – Result of upsized oversubscribed BookBuild Offer May 23, 2025 – Posted in: Poolbeg Pharma (POLB)
Result of upsized and oversubscribed BookBuild Offer · Conditionally raised gross proceeds of £150,000 from the upsized and oversubscribed BookBuild Offer · Total gross proceeds conditionally raised pursuant to the Fundraising therefore increased to £4.865 million · Use of net proceeds from the Fundraising: o Phase 2a clinical trial for POLB 001, targeting prevention of cancer immunotherapy-induced Cytokine Release Syndrome (CRS) o Oral GLP-1 proof-of-concept clinical trial o Cash runway extended through to 2027 Poolbeg Pharma…
Continue reading